Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $37.0000 (-5.73%) ($36.0000 - $38.6000) on Tue. Sep. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.91% (three month average) | RSI | 50 | Latest Price | $37.0000(-5.73%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 5.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWG(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.455% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.455% (StdDev 4.91%) | Hourly BBV | 0 () | Intraday Trend | -2.9% | | | |
|
5 Day Moving Average | $39.05(-5.25%) | 10 Day Moving Average | $38.02(-2.68%) | 20 Day Moving Average | $36.96(0.11%) | To recent high | -22.1% | To recent low | 9.7% | Market Cap | $729m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |